Filipinas - inglês - FDA (Food And Drug Administration)

i.e. medica inc.; distributor: united pharma plus (unipharm), inc. - omeprazole - lyophilized powder for injection - 40mg

Filipinas - inglês - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: united pharma plus (unipharma),inc. - omeprazole - delayed release capsule - 40 mg

Arábia Saudita - inglês - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

life pulse medical company, saudi arabia - capsule, soft - 62.5, 80, 215, 100, 35 mg - pomegranate dry extract, saw palmetto fruit extract, pumpkin seeds oil, nettle leaf dry extract, tomato oleoresin

Arábia Saudita - inglês - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

62.5, 80, 215, 100, 35 mg

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

bristol-myers squibb (holdings) limited - sotalol hydrochloride - tablets - 80 milligram - beta blocking agents, non-selective

Israel - inglês - Ministry of Health

bristol, myers squibb (israel) limited, israel - elotuzumab - powder for concentrate for solution for infusion - elotuzumab 300 mg/vial - elotuzumab - empliciti is indicated in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment ofadult patients with relapsed and refractory multiple myeloma who have received at least two priortherapies, including lenalidomide and a proteasome inhibitor, and have demonstrated diseaseprogression on the last therapy.

Israel - inglês - Ministry of Health

bristol, myers squibb (israel) limited, israel - elotuzumab - powder for concentrate for solution for infusion - elotuzumab 400 mg/vial - elotuzumab - empliciti is indicated in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.empliciti is indicated in combination with pomalidomide and dexamethasone for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have demonstrated disease progression on the last therapy.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

euro implants pty ltd - 40646 - nuclear medicine system, hand-held detector - wprobe is a wireless ionising radiation detector probe for use in the medical sector. in particular, it is a wireless intraoperative probe for detecting gamma radiation in radio guided surgery.